These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21839323)

  • 1. Lenalidomide-induced purpuric eruption: a new adverse cutaneous reaction.
    Kuohung V; Goldberg LJ; Demierre MF
    J Am Acad Dermatol; 2011 Sep; 65(3):654-656. PubMed ID: 21839323
    [No Abstract]   [Full Text] [Related]  

  • 2. Purpuric drug eruption possibly due to gefinitib (Iressa).
    Kurokawa I; Endo K; Hirabayashi M
    Int J Dermatol; 2005 Feb; 44(2):167-8. PubMed ID: 15689221
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe purpuric xerotic dermatitis associated with gefitinib therapy.
    Sheen YS; Hsiao CH; Chu CY
    Arch Dermatol; 2008 Feb; 144(2):269-70. PubMed ID: 18283195
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous adverse reactions to lenalidomide.
    Imbesi S; Allegra A; Calapai G; Musolino C; Gangemi S
    Allergol Immunopathol (Madr); 2015; 43(1):88-91. PubMed ID: 24998775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Livedo reticularis with retiform purpura associated with gefitinib (Iressa).
    Blume JE; Miller CC
    Int J Dermatol; 2007 Dec; 46(12):1307-8. PubMed ID: 18173531
    [No Abstract]   [Full Text] [Related]  

  • 6. Teicoplanin-induced purpuric eruption with leukocytoclastic vasculitis.
    Uchida Y; Higashi Y; Kanekura T
    Eur J Dermatol; 2014; 24(6):689-90. PubMed ID: 25179378
    [No Abstract]   [Full Text] [Related]  

  • 7. Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma.
    Sviggum HP; Davis MD; Rajkumar SV; Dispenzieri A
    Arch Dermatol; 2006 Oct; 142(10):1298-302. PubMed ID: 17043184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lenalidomide-induced tumour flare reaction in mantle cell lymphoma.
    Eve HE; Rule SA
    Br J Haematol; 2010 Nov; 151(4):410-2. PubMed ID: 20880113
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide.
    Foti C; Antelmi A; Mazzocca A; Saverio Vella F; Romita P; Pugliese S; Lomazzo D; Portincasa P; Palasciano G
    Eur J Dermatol; 2012; 22(6):799-800. PubMed ID: 23137713
    [No Abstract]   [Full Text] [Related]  

  • 10. [Papular drug eruption along the lines of Blaschko caused by lenalidomide].
    Grape J; Frosch P
    Hautarzt; 2011 Aug; 62(8):618-20. PubMed ID: 21445702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Petechial and purpuric eruption induced by lidocaine/prilocaine cream: a rare side effect.
    Roldán-Marín R; de-la-Barreda Becerril F
    J Drugs Dermatol; 2009 Mar; 8(3):287-8. PubMed ID: 19271379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lenalidomide cutaneous adverse event: a case of Stevens-Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone.
    Siniscalchi A; Tendas A; Morino L; Dentamaro T; De Bellis A; Perrotti A; de Fabritiis P; Musto P; Caravita T
    Support Care Cancer; 2012 Jul; 20(7):1585-7. PubMed ID: 22562584
    [No Abstract]   [Full Text] [Related]  

  • 13. Quinidine-induced photosensitive livedo reticularis-like eruption.
    Bruce S; Wolf JE
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):332-6. PubMed ID: 3156160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid-induced purpuric medication reaction.
    Kim FS; Kelley W; Resh B; Goldenberg G
    J Cutan Pathol; 2009 Jul; 36(7):793-5. PubMed ID: 19519611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glipizide-induced pigmented purpuric dermatosis.
    Adams BB; Gadenne AS
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):827-9. PubMed ID: 10534660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects.
    Patrizi A; Venturi M; Dika E; Maibach H; Tacchetti P; Brandi G
    Cutan Ocul Toxicol; 2014 Mar; 33(1):1-6. PubMed ID: 23638756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bufexamac-induced pigmented purpuric eruption].
    Waltermann K; Marsch WCh; Kreft B
    Hautarzt; 2009 May; 60(5):424-7. PubMed ID: 19093092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenalidomide: a new agent for patients with relapsed or refractory multiple myeloma.
    Tariman JD
    Clin J Oncol Nurs; 2007 Aug; 11(4):569-74. PubMed ID: 17723971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab-induced eczematid-like purpura of Doucas and Kapetenakis.
    Wang LC; Medenica MM; Shea CR; Busbey S
    J Am Acad Dermatol; 2003 Jul; 49(1):157-8. PubMed ID: 12833033
    [No Abstract]   [Full Text] [Related]  

  • 20. Figurate purpuric eruptions on the trunk: acetaminophen-induced rashes.
    Kwon SJ; Lee CW
    J Dermatol; 1998 Nov; 25(11):756-8. PubMed ID: 9863291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.